SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Landec Corporation on September 9, 2004, covering events occurring on September 3, 2004, and September 9, 2004. The filing details a strategic partnership and equity transaction with Chiquita Brands International, Inc. Note: The input metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION".
Key Financial Metrics and Transaction Details
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or debt levels. Instead, it outlines a specific unregistered sale of equity securities:
- Transaction Type: Stock Purchase Agreement for up to 500,000 shares of Landec Common Stock.
- Counterparty: Chiquita Brands International, Inc. (an accredited investor).
- Pricing Mechanism: The price per share is the greater of (i) the volume-weighted average price (VWAP) over a 20-day period (capped at $7.20) or (ii) the closing price on the trading day preceding the public announcement.
- Share Quantity Formula:
- If price >= $6.00: Lesser of 500,000 shares or $3,500,000 divided by the price.
- If price < $6.00: $2,000,000 divided by the price (or $1,000,000 divided by the price if VWAP is less than the initial trading price).
- Settlement Date: The 25th trading day following the first public announcement of the License Agreement.
Material Changes and Strategic Events
On September 9, 2004, Landec announced a joint technology development and supply agreement with Chiquita. Under this agreement, Landec will provide its patented Intelimer packaging technology for Chiquita Brand bananas. This strategic alliance is the catalyst for the concurrent equity investment by Chiquita.
Outlook, Risks, and Contingencies
The filing relies on exemptions from registration requirements under Section 4(2) of the Securities Act and Rule 506 of Regulation D. Chiquita has represented that it intends to acquire the stock for investment purposes only and not for resale in connection with a distribution. The filing does not provide specific forward-looking financial guidance or detailed risk factors beyond the standard regulatory disclosures for unregistered securities sales.
Key Facts for Investor Verification
- Verify the final share count and price per share once the 20-day VWAP period concludes and the transaction settles.
- Confirm the commercial terms and revenue potential of the Intelimer packaging technology supply agreement with Chiquita.
- Monitor the impact of the potential dilution from the issuance of up to 500,000 new shares.
- Review the full text of the Stock Purchase Agreement (Exhibit 10.56) and the Press Release (Exhibit 99.1) for specific covenants and performance milestones.